Image
Stem Cell Capital
Stem Cell Capital

Life Sciences & Technology Transaction Advisory

Stem Cell Capital is an investment advisory firm specializing in cross-border transactions, raising early stage, growth and acquisitive capital and providing financial & strategic advisory services to entrepreneurs and companies across emerging and high growth sectors such as Life sciences (covering broadly, Pharma, Biotech, Healthcare, Medical Devices, Diagnostics, Contract Research, Formulation and Manufacturing Services, & Chemicals), and related Technology (Bio-IT, Healthcare-IT). More opportunistically, we sometimes look at pure tech deals which may have applications as enablers of healthcare (Software, Telecommunications, Internet, Digital Media) across the global business ecosystem.

OUR SERVICES

Stem Cell Capital provides the following services for promising early-stage and growth-oriented firms operating or intending to operate along the India-US corridor. Funding is provided for growth stage companies in the mid-market space in the range of US $2-200M. Our investment philosophy and process is based on fundamental and technical analysis of your current business operations, competitor comparison and edge analysis, projected cash flows and earnings streams, evaluation of management team and existing corporate structure and review of legal and accounting procedures.

LIFE SCIENCES INVESTMENT ADVISORY

Why Stem Cell

Why Stem Cell* Capital

Stem Cell's investment and advisory team comprises of professionals who bring in decades of top-tier scientific, business and finance credentials from leading academic institutions and companies covering the technical, operational and financial aspects of running a business. The firm has, in addition, access to top investment professionals as well as growth and acquisitive capital through VC and PE networks, which provides the firm with access to the latest thought leadership and critical financing that translates into immediate value to clients.

The firm is uniquely positioned to provide cutting-edge and cross-cultural expertise to clients through our existing relationships with domestic and cross-border financial institutions, early-/growth-stage investors, and senior and C-level contacts in the industry.

*Nature's nanofactories - pluripotent cells that can be induced to develop into any functional cell, tissue or organ. An analogy for growth capital or acquisitive strategies to an organization.

Image
Stem Cell Capital
Service Approach

Unique Full-service Approach

We follow a philosophy of "Culture & Nurture" - a holistic approach focused on providing an end to end solution to clients – designing strategies for sustainable organic growth based on a company’s current state vis-a-vis the market; securing early-stage, growth or acquisitive financing; and, executing M&A (or licensing, alliances and partnerships) transactions for inorganic growth.

Team

Stem Cell Capital Leadership

Read More
Life Sciences Incubator

Stem Cell Life Sciences Incubator

Stem Cell Capital has established a virtual incubator to provide entrepreneurs with assistance in obtaining funding and operational support to establish and run their businesses from start up to successful execution. Visit the Incubator page for more information and to submit a business plan.

Stem Cell Capital News

Industry News, Reports & Analysis

Industry News, Reports & Analysis

Daiichi-Sankyo's acquisition of India's largest drug maker Ranbaxy and Sanofi-Pasteur's acquisition of Shantha Biotechnics.
Read More

Stem Cell Capital News

(March 2008) SCC established as a specialist life sciences investment advisory with a focus on cross-border transactions
Read More
Contact US

Lets get in touch

Address

Companies seeking M & A advisory, capital raising as well as technical, strategic and outreach services

Phone Number

+1 717 704 0297